Entresto vs Pomalyst
Side-by-side drug price comparison from Medicare Part D data
Verdict
Entresto costs 98% less per claim than Pomalyst ($379.00 vs $17250.00). Neither drug has a generic alternative available. Total Medicare spending: Entresto at $4.8B vs Pomalyst at $3.3B.
| Metric | Entresto | Pomalyst |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $379* | $17,250 |
| Total Medicare Spending Total Medicare Part D spending on this drug | $4.8B | $3.3B |
| Total Claims | 12,560,000 | 192,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | 18.3% | 4.7%* |
| Generic Available | No | No |
| Condition | Heart Failure | Cancer |
| Total Beneficiaries | 1,085,000 | 18,000 |
Entresto costs 98% less per claim than Pomalyst ($379.00 vs $17250.00). Neither drug has a generic alternative available. Total Medicare spending: Entresto at $4.8B vs Pomalyst at $3.3B.